Litigation Note: Crowell & Moring Secures IP Victory for Watson Pharmaceuticals (now Actavis)
Firm News | less than 1 min read | 04.15.13
Washington, D.C. – April 15, 2013: Crowell & Moring represented Watson Pharmaceuticals, Inc. (now Actavis, Inc.) in successfully defending the patent infringement case brought by Bayer HealthCare Pharmaceuticals Inc. regarding its RE37,564 patent for the Yaz ® contraceptive. Today, the Federal Circuit reversed the adverse summary judgment decision made by the district court in March 2012 and held that Bayer's asserted patent claims were invalid. The court found that the cited prior art references set forth every limitation required by the asserted claims and provide express motivation to combine those teachings to derive the claimed oral contraceptive product. As a result of the decision today, Actavis has re-launched its generic product.
Insights
Firm News | 2 min read | 07.09.25
Amica Center Honors Crowell & Moring with Defenders of Due Process Award
Washington – July 8, 2025: The Amica Center for Immigrant Rights, formerly known as Capital Area Immigrants’ Rights (CAIR) Coalition, has honored Crowell & Moring with the Defenders of Due Process Award. Crowell was recognized for its commitment to “provide unwavering strategic litigation for immigrant children and adults facing detention and deportation.” The award will be presented at the annual Fall Fundraiser on October 8 in Washington, D.C.
Firm News | 2 min read | 07.09.25
Firm News | 1 min read | 07.09.25
Tahirih Justice Center Honors Crowell & Moring with Pro Bono Team of the Year Recognition
Firm News | 3 min read | 07.08.25
Crowell & Moring Client CSX Wins Summary Judgment in 18-Year Antitrust Litigation